Login / Signup

Pre-treatment [ 18 F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma.

Jing ChenYi Zhao
Published in: Hematology (Amsterdam, Netherlands) (2024)
PET/CT has a complementary role in assessing BMI and an ability to predict prognosis in PTCL patients.
Keyphrases
  • newly diagnosed
  • pet ct
  • bone marrow
  • end stage renal disease
  • ejection fraction
  • mesenchymal stem cells
  • body mass index
  • positron emission tomography
  • weight gain
  • weight loss
  • patient reported